Public IDs

No public external ID is attached.

Related people

No reviewed person affiliation is attached.

Outputs

No reviewed output is linked through affiliated people.

Topics

Protein and Drug DesignSourceInternational Journal of Newgen Research in Pharmacy & Healthcare SourceClinicalTrials.gov

Relationship evidence

A Randomized, Open-Label, Controlled, Multicenter Phase III Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer

A Randomized, Open-Label, Controlled, Multicenter Phase III Clinical Study of SHR-A1811 in Combination With Chemotherapy and Bevacizumab Versus Standard Therapy as First-Line Treatment for Advanced Colorectal Cancer (NCT07676162)

PRODUCED BYincoming82% confidence

SourceClinicalTrials.gov

Timeline

No dated relationship evidence is attached.